PTO Strikes Down Ariad's Patent
The U.S. Patent & Trademark Office has invalidated 160 of 203 claims on a patent that is vital to Ariad Pharmaceuticals Inc.'s case against rival Eli Lilly & Co....To view the full article, register now.
Already a subscriber? Click here to view full article